Fischer J F, Wenzel D
Z Gesamte Inn Med. 1979 Apr 1;34(7):65-7.
In the treatment of the obstructive ventilation disturbance in bronchial asthma the beta 2-receptor stimulants and the inhalable corticoids best proved. With the help of own clinical experiences and studies of literature Arubendol, Salbutamol, Berotec, Auxiloson and Beclomethason are described and it is reported on their bronchospasmolytic qualities as well as their protective effect against repeated acetylcholin and allergen irritation, respectively. They all distinguish themselves by a selective effect on the bronchial system and in therapeutic doses they guarantee the absence of systemic side effects. Though with Arubendol a secure beta 2-receptor stimulants with a good protective effect against acetylcholin and allergen irritation is at our disposal, the application of Berotec and of in inhalable corticoid would be an effective enrichment of our antiasthmatic remedies.
在支气管哮喘阻塞性通气障碍的治疗中，β2受体激动剂和吸入性皮质类固醇效果最佳。根据自身临床经验和文献研究，对阿鲁本多、沙丁胺醇、博利康尼、奥克西龙和倍氯米松进行了描述，并分别报告了它们的支气管解痉特性以及对反复乙酰胆碱和过敏原刺激的保护作用。它们都以对支气管系统的选择性作用而著称，在治疗剂量下可确保无全身副作用。虽然我们有阿鲁本多这种对乙酰胆碱和过敏原刺激具有良好保护作用的可靠β2受体激动剂，但应用博利康尼和吸入性皮质类固醇将有效丰富我们的抗哮喘药物。
